Q2 2017
Released Aug 7, 2017, before the open
10-Q filed Aug 7, 2017, 38 days after period end · 0001144204-17-040693
Q2 2017 · 10-Q
Revenue$0.00$0.00 no prior Q2 2016 on fileno prior Q1 2017 on file
Net Income-$6.09M-$6.09M N/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$0.31-$0.31 N/M vs Q2 2016N/M vs Q1 2017
Operating Income-$6,140,618N/M
Operating Cash Flowderived-$4,700,559N/M
Free Cash Flowderived-$4,700,559N/M
What the release said
The release
Same quarter
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | — |
| Net Income | -$6.09M | -$5.76M | -$4.25M | -$6.97M |
| EPS Diluted | -$0.31 | -$0.32 | -$0.26 | -$0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR